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The influence of human recombinant interleukin-la (hrIL-I) on biosynthesis of collagenase and glycosaminoglycans was 
investigated with fibroblast-like cells of human chorionic membrane. hrIL-1 stimulated cells to produce procollagenase 
in a dose-dependent manner. Furthermore, it similarly accelerated both biosynthesis and secretion of hyaluronic acid 
in chorionic cells, but did not modulate the biosynthesis of sulfated glycosaminoglycans. Therefore, the relative concen- 
tration of hyaluronic acid vs total glycosaminoglycans increased significantly. These results are connected with the de- 
crease in tensile strength observed in ruptured fetal membranes. Thus, it is proposed that IL-I from effused leukocytes 
in fetal membranes plays an important role in connective tissue metabolism, especially in premature rupture of mem- 
branes with chorioamnionitis. 
Interleukin-la, recombinant; Collagenase; Collagen; Hyaluronic acid; (Human chorionic cell) 
1. INTRODUCTION 
Interleukin-1 is known to exert a number of 
biological effects in vivo and in vitro [l]. It has 
been shown to be one of the inflammatory 
mediators [l] and to participate in connective 
tissue matrix catabolism [2]. The degradation of 
extracellular matrix components induced by IL-l is 
believed to be due to the accelerated production of 
proteolytic enzymes by connective tissue cells, 
especially synovial fibroblasts and chondrocytes 
[3-51. Different effects of IL-l, however, on the 
biosynthesis of glycosaminoglycans are observed 
in those cells [6,7]. Furthermore, the precise in- 
fluence of IL-l on the connective tissue 
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metabolism in the other cells has not been fully 
understood. 
Chorioamniotic membranes are known to con- 
sist mainly of collagen [8] and glycosaminoglycans 
191, and these connective tissue components are 
considered to maintain the elasticity of the mem- 
branes [lo]. Therefore, it is supposed that pro- 
found biochemical changes in the connective tissue 
of membranes are closely connected with a reduc- 
tion in elasticity of prematurely ruptured fetal 
membranes and also of normally ruptured ones at 
term pregnancy. However, at present, the precise 
mechanism for the reduction of tensile strength of 
those membranes has not been clarified. Maternal 
leukocytes might be a major cause of this reduc- 
tion, since effusion of maternal ones is frequently 
observed on prematurely ruptured fetal mem- 
branes [12,13] and normally ruptured ones at term 
pregnancy [14]. In order to clarify the correlation 
between leukocytes and the reduction of tensile 
strength of the above membranes, we have exam- 
ined the effect of a leukocyte factor, IL-I, on the 
connective tissue metabolism in human chorionic 
cells. 
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Here, we report that hrIL-1 enhances the pro- 
duction of collagenase and hyaluronic acid in 
human chorionic cells, and that IL-l plays an im- 
portant role in connective tissue metabolism of 
fetal membranes. 
2. MATERIALS AND METHODS 
The following reagents were obtained commercially: MEM 
from Grand Island Biological (Grand Island, NY); FBS from 
Whittaker M.A. Bioproducts (Walkersville, MD); D- 
[6-3H]glucosamine hydrochloride (22.6 Ci/mmol) from The 
Radiochemical Center (Amersham, Bucks, England); chon- 
droitin AC lyase (EC 4.2.2.5) and chondroitin ABC lyase (EC 
4.2.2.4) from Seikagaku Kogyo (Tokyo). hrIL-1 (2 x 
10’ U/mg) was kindly donated by Dainippon Pharmaceutical 
Co. (Suita, Osaka). Other reagents used were the same as 
described [15]. 
2.1. Culture of human chorionic cells 
Human fetal membranes were collected at delivery from term 
pregnancies. The chorionic membrane was separated manually 
from the amniotic membranes and washed sufficiently with 
PBS( -)/penicillin G (200 U/ml) and streptomycin (200 rg/ 
ml). Chorionic cells were prepared and cultured as described for 
uterine cervical cells of rabbits (15,161. The membranes were 
digested with bacterial collagenase in HBSS( -)/antibiotics for 
20 min at 37°C. The digest was passed through a nylon mesh 
and cells were then collected by low-speed centrifugation and 
washed twice with HBSS( -) followed by MEM/lO% (v/v) 
FBS/antibiotics. The cells were maintained to confluency in a 
culture of MEM/lO% (v/v) FBS under 5% c&-95% air at 
37°C. In this series of experiments, human chorionic cells were 
used at passage level 1-6. 
2.2. Collagenase production 
Subcultured human chorionic cells were suspended in 
MEM/lO% (v/v) FBS, placed in 35mm Corning plastic dishes 
(1.5 ml/dish, 5 x lo4 cells) and maintained to confluency. For 
production of collagenase, the culture medium was changed to 
MEM/O.Z% (w/v) lactalbumin hydrolysate. The culture media 
harvested were centrifuged at 1300 x g and then stored at 
- 20°C until use. 
2.3. Biosynthesis of glycosaminoglycans by human chorionic 
cells 
Confluent chorionic cells in 35-mm plastic dishes were in- 
cubated with 10 pCi D-[6-‘Hlglucosamine hydrochloride for 
l-24 h in a culture medium of MEM/antibiotics. The incuba- 
tion medium was removed from each dish and cells on the dish 
washed twice with PBS( -). The medium and washes were com- 
bined and designated as the medium fraction. The residue (cell 
fraction) was treated with 0.5 M NaOH for 24 h at room 
temperature and then collected. Extraction of glycosaminogly- 
cans from each fraction, digestion of glycosaminoglycans with 
chondroitin AB lyase and ABC lyase, and estimation of 
unsaturated isaccharides were performed as in [17]. 
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2.4. Assay for collagenase activity 
Collagenase was assayed by the fibril assay using [“Cl- 
acetylated collagen and total collagenase activity determined by 
the activation of procollagenase with trypsin as in [15]. One unit 
of collagenase hydrolyzes 1 gg substrate/min at 37°C. 
3. RESULTS 
When confluent human chorionic cells were 
treated with various amounts of hrIL-1, cells pro- 
duced much collagenase activity as a latent form 
and the apparent collagenase activity in culture 
media increased in a dose-dependent manner as 
shown in fig.1. Untreated cells, however, did not 
produce any collagenolytic activity. The maximal 
effect of hrIL-1 was observed at around 
0.25 ng/ml. On the other hand, measuring the syn- 
thesis of [3H]proline-labeled macromolecules in- 
dicated that hrIL-1 did not modulate the syntheses 
of collagen and non-collagenous protein in 
chorionic cells (not shown). 
When confluent chorionic cells were incubated 
with D-[6-3H]glucosamine, cells secreted about 
75% of the synthesized glycosaminoglycans into 
the medium, and the total radioactivity of 
glycosaminoglycans synthesized increased approx- 
imately linearly throughout the incubation period 
(up to 24 h, not shown). 
hrIL-1 enhanced significantly the accumulation 
I I 
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Fig.1. Effect of hrIL-1 on the production of collagenolytic 
activity by human chorionic cells. Chorionic cells at the fourth 
passage were maintained to confluence as described in the text 
and cells were then treated with hrIL-1 in 0.2% (w/v) 
lactalbumin hydrolysate/MEM for 48 h. Aliquots (100~1) of 
the medium were assayed for total collagenolytic activity as 
described in the text. Data are represented as means + SD of 4 
dishes. 
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Fig.2. Dose-dependent effect of hrlL-1 on the production of 
glycosaminoglycans by human chorionic cells. Chorionic cells 
at fifth passage were grown to confluence in 1.5 ml of 10% 
(v/v) FBWMEM, and cells were then treated with various 
concentrations of hrlL-1 for 24 h. The medium was then 
changed to FBS-free/MEM containing hrlL-1 and cells were 
labeled with 10 pCi D-[6-3H]glucosamine for 24 h. Glycosami- 
noglycans in cell (0) and medium (0) fractions were extracted 
and purified as described in the text. Data are shown as the 
means + SD of 4 dishes. 
of extracellular glycosaminoglycans in a dose- 
dependent manner, indicating that hrIL-I ac- 
celerates both biosynthesis and secretion of 
glycosaminoglycans in chorionic cells as shown in 
fig.2. Furthermore, the effect of hrIL-1 on the 
composition of glycosaminoglycans synthesized in 
human chorionic cells was examined. As shown in 
table 1, hrIL-1 accelerated specifically the biosyn- 
thesis of hyaluronic acid and thus increased 
significantly its ratio to total glycosaminoglycans. 
In contrast, the ratios of chondroitin sulfate and 
dermatan sulfate were decreased markedly com- 
pared to each control. 
4. DISCUSSION 
It has been reported that collagen content in 
prematurely ruptured amniotic membranes is 
characteristically low in comparison with those 
without premature rupturing [ 18,191. In addition, 
Skinner and Liggins [9] have reported the marked 
decreases in concentration of sulfated glycosami- 
noglycans and collagen in term and post-term am- 
nions and in some cases of premature rupture of 
membranes. In contrast, the hyaluronate concen- 
tration in those amnions was obviously increased. 
Therefore, they concluded that these changes can 
be explained well by connective tissue remodeling 
which causes the decrease in tensile strength of 
fetal membranes. They also proposed that in some 
clinical disorders such as amnionitis, some factors 
of the inflammatory process may initiate the 
remodeling of connective tissue [9]. In this respect, 
it is interesting to note that effusion of maternal 
polymorphonuclear leukocytes into the chorionic 
membrane has been observed with the progression 
of amniotic infection [20]. In addition, it is known 
that effusion of maternal macrophages is observed 
Table 1 
Effect of hrlL-1 on the composition of glycosaminoglycans produced by human chorionic 
cells 
Glycosaminoglycans (dpm x 10W4/dish) 
Chs DS HA HS Total 
Total (cell and medium fractions) 
Control 5.34 + 0.22 4.21 + 0.32 18.67 f 1.35 0.38 + 0.24 28.62 f 1.66 
(18.8 + 0.3) (14.7 + 0.3) (65.2 + 1.0) (1.4 f 0.9) 
hrlL-1 5.49 + 0.25 5.64 + 0.34 48.75 + OJNb 0.99 zt 0.22 60.86 + 0.19b 
(9.0 + 0.4)b (9.3 + 0.6)a (80.1 + O.l)b (1.6 k 0.3) 
Control and hrlL-1 (1 ng/ml)-treated samples in fig.2 were employed for this assay. 
Results are calculated from descending paper chromatography of chondroitin AC lyase- 
or ABC lyase-digested glycosaminoglycans. Data are shown as means + SD of 4 dishes. 
Relative composition is represented in parentheses. Chs, chondroitin sulfate; DS, 
dermatan sulfate; HA, hyaluronic acid; HS, heparan sulfate. a and b: significantly 
different from each control @ < 0.05 and p < 0.01) 
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in normal chorionic membrane at term pregnancy 
[14] and that placenta at post-parturition is a 
source of IL-l [21]. These observations uggest he 
significance of IL-l during the rupture of fetal 
membranes, since both monocytes/macrophages 
[l] and polymorphonuclear leukocytes [22] are 
recognized as being typical IL-l-producing cells. 
When fibroblast-like cells from human chorion 
were treated with hrIL-1, collagenase production 
was enhanced in a dose-dependent manner as 
reported in synovial fibroblasts and chondrocytes 
[3-51, indicating that IL-l promotes collagenolysis 
in human chorionic membrane. In addition, IL-l 
preferentially stimulates the biosynthesis and 
secretion of hyaluronic acid in these cells without 
affecting those of sulfated glycosaminoglycans. 
Therefore, the relative concentration of hyaluron- 
ate vs total glycosaminoglycans inevitably increas- 
ed. This promoting effect of IL-l results in further 
acceleration of reducing the tensile strength of the 
fetal membranes, because of the highly hydrophilic 
nature of hyaluronic acid and the significant 
decrease in dermatan sulfate which interacts 
strongly with collagens. These effects of IL-l on 
connective tissue are identical with those observed 
in prematurely ruptured fetal membranes and nor- 
mally ruptured ones at term pregnancy [9]. 
In conclusion, IL-l may play an important role 
in connective tissue metabolism in fetal mem- 
branes with chorioamnionitis, and also participate 
in connective tissue catabolism in normal ruptur- 
ing of fetal membranes at term pregnancy. 
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